Status | Study |
Completed |
Study Name: Study of Repetitive Intestinal Lavage in Patients With EHEC Associated Hemorrhagic Colitis Condition: Hemolytic Uremic Syndrome Hemorrhagic Colitis Intestinal I Date: 2012-01-23 Interventions: Drug: polyethylene glycol solution for daily bowel lavage. At admission,patients with severe EHEC infect |
Completed |
Study Name: Outbreak of Hemolytic Uremic Syndrome Linked to Escherichia Coli of Serotype O104:H4 Condition: Hemolytic-uremic Syndrome Escherichia Coli Infections Date: 2011-07-28 Interventions: Other: HUS standard coverage care (including in ICU) HUS standard coverage care : plasmaphereses - eculi |
Completed |
Study Name: Safety Study of Recombinant Vaccine to Prevent ETEC Diarrhea Condition: Escherichia Coli Infection Date: 2011-06-23 Interventions: Biological: Recombinant fimbrial adhesin dscCfaE |
Completed |
Study Name: Colonization With Extended-Spectrum Beta-Lactamase (ESBL)-Producing Organisms Condition: Escherichia Coli Infections Klebsiella Pneumonia Date: 2011-03-28 |
Completed |
Study Name: Prevention of Nosocomial E. Coli Infections After Placement of an Indwelling Catheter During Pelvic Surgery: an Evaluation of Cranberry Gel Capsules Condition: Cross Infection Bacteriuria Date: 2010-04-30 Interventions: Dietary Supplement: cranberry type A pro anthocyandines |
Active, not recruiting |
Study Name: Clinical and Microbiologic Characteristics of Cephalosporin-Resistant E. Coli-PITT Protocol Condition: E Coli Infections Date: 2009-04-07 |
Completed |
Study Name: Safety and Immunogenicity of Peru-15-pCTB in Healthy Adult Subjects Condition: Escherichia Coli Infections Date: 2008-04-03 Interventions: Drug: Ciprofloxacin 500 mg 500 |
Withdrawn |
Study Name: Ampicillin-sulbactam Resistant E.Coli at UPMC Condition: Positive E Coli Infections Date: 2008-02-07 |
Terminated |
Study Name: Enteroaggregative E.Coli (EAEC) Condition: Escherichia Coli Infections Date: 2006-08-10 Interventions: Drug: Levofloxacin Administere |
Completed |
Study Name: Community - Associated Extended-spectrum Beta-lactamases (ESBL) Condition: Infection E Coli Infections K Date: 2006-08-10 |